Outlook Therapeutics (OTLK)
NASDAQ:OTLK
Holding OTLK?
Track your performance easily

Outlook Therapeutics (OTLK) Technical Analysis

1,171 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Outlook Therapeutics’s (OTLK) Moving Averages Convergence Divergence (MACD) indicator is 0.13, suggesting Outlook Therapeutics is a Sell.
Outlook Therapeutics’s (OTLK) 20-Day exponential moving average is 5.78, while Outlook Therapeutics’s (OTLK) share price is $6.51, making it a Buy.
Outlook Therapeutics’s (OTLK) 50-Day exponential moving average is 6.01, while Outlook Therapeutics’s (OTLK) share price is $6.51, making it a Buy.

Outlook Therapeutics (OTLK) Pivot Points

Nov 10, 2024, 02:05 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.75
5.88
6.11
6.24
6.47
6.60
6.83
Fibonacci
5.88
6.01
6.10
6.24
6.37
6.46
6.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Outlook Therapeutics (OTLK) Moving Averages

Nov 10, 2024, 02:05 AM
Period
Simple
Exponential
MA5
6.15Buy
6.20Buy
MA10
5.88Buy
5.97Buy
MA20
5.56Buy
5.78Buy
MA50
5.97Buy
6.01Buy
MA100
6.82Sell
6.56Sell
MA200
7.50Sell
7.24Sell
Outlook Therapeutics’s (OTLK) 10-Day exponential moving average is 5.97, while Outlook Therapeutics’s (OTLK) share price is $6.51, making it a Buy.
Outlook Therapeutics’s (OTLK) 100-Day exponential moving average is 6.56, while Outlook Therapeutics’s (OTLK) share price is $6.51, making it a Sell.
Outlook Therapeutics’s (OTLK) stock price is $6.51 and Outlook Therapeutics’s (OTLK) 50-day simple moving average is 5.97, creating a Buy signal.
Outlook Therapeutics’s (OTLK) stock price is $6.51 and Outlook Therapeutics’s (OTLK) 100-day simple moving average is 6.82, creating a Sell signal.
Outlook Therapeutics’s (OTLK) stock price is $6.51 and Outlook Therapeutics’s (OTLK) 200-day simple moving average is 7.50, creating a Sell signal.

Outlook Therapeutics (OTLK) Technical Indicators

Nov 10, 2024, 02:05 AM
Name
Value
Implied Action
RSI (14)
69.01
Neutral
STOCH (9,6)
90.61
Sell
STOCHRSI (14)
91.62
Sell
MACD (12,26)
0.13
Sell
ADX (14)
25.56
Neutral
Williams %R
-10.67
Sell
CCI (14)
177.58
Sell
ATR (14)
0.33
-
Ultimate Oscillator
59.53
Neutral
ROC
26.65
Buy
Outlook Therapeutics’s (OTLK) Relative Strength Index (RSI) is 69.01, creating a Neutral signal.
Outlook Therapeutics’s (OTLK) Trend Strength Indicator (ADX) is 25.56, creating a Neutral signal.
Outlook Therapeutics’s (OTLK) Commodity Channel Index (CCI) is 177.58, creating a Sell signal.
Outlook Therapeutics’s (OTLK) Price Rate of Change (ROC) is 26.65, creating a Buy signal.

FAQ

Is OTLK a Buy, Hold, or Sell?
Based on OTLK’s technical indicators, OTLK is a Hold.
    What is OTLK’s RSI (14)?
    OTLK’s RSI (14) is 69.01, which suggests OTLK is a Neutral.
      What is OTLK’s MACD?
      OTLK’s MACD is 0.13, which suggests OTLK is a Sell.
        What is OTLK’s 5-day moving average?
        OTLK’s 5-day moving average is 6.15, which suggests OTLK is a Buy.
          What is OTLK’s 20-day moving average?
          OTLK 20-day moving average is 5.56, which suggests OTLK is a Buy.
            What is OTLK’s 50-day moving average?
            OTLK’s 50-day moving average is 5.97, which suggests OTLK is a Buy.
              What is OTLK’s 200-day moving average?
              OTLK’s 200-day moving average is 7.50, which suggests OTLK is a Sell.
                What is OTLK’s Williams % R (14)?
                OTLK’s Williams % R (14) is -10.67, which suggests OTLK is a Sell.
                  What is OTLK’s CCI (14)?
                  OTLK’s CCI (14) is 177.58, which suggests OTLK is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis